Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Total Non-Current Liabilities (2016 - 2025)

Haemonetics has reported Total Non-Current Liabilities over the past 16 years, most recently at $1.5 billion for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $1.5 billion for Q4 2025, down 1.21% from a year ago — trailing twelve months through Dec 2025 was $1.5 billion (down 1.21% YoY), and the annual figure for FY2025 was $1.6 billion, up 34.58%.
  • Total Non-Current Liabilities for Q4 2025 was $1.5 billion at Haemonetics, down from $1.5 billion in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for HAE hit a ceiling of $1.6 billion in Q1 2025 and a floor of $976.2 million in Q3 2022.
  • Median Total Non-Current Liabilities over the past 5 years was $1.1 billion (2022), compared with a mean of $1.2 billion.
  • Peak annual rise in Total Non-Current Liabilities hit 104.19% in 2022, while the deepest fall reached 4.29% in 2022.
  • Haemonetics' Total Non-Current Liabilities stood at $1.0 billion in 2021, then rose by 1.26% to $1.0 billion in 2022, then rose by 15.33% to $1.2 billion in 2023, then grew by 29.94% to $1.5 billion in 2024, then fell by 1.21% to $1.5 billion in 2025.
  • The last three reported values for Total Non-Current Liabilities were $1.5 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025) per Business Quant data.